Events

Filter by:

Limit to events where the title matches:
Limit to events where the first date of the event:
Date range
Limit to events where the first date of the event:
Limit to events where the type is one or more of:
Limit to events tagged with one or more of:
Limit to events where the audience is one or more of:
Monday, April 2, 2018 12:30 pm - 2:30 pm EDT (GMT -04:00)

UWaterloo Intellectual Property Workshop Series

IP Series Poster
Series Information:

  • Tuesday January 16 - 12:30-2:30 pm – IP 101 and Commercialization 

  • Tuesday February 13 - 12:30-2:00 pm – IP Case Study

  • Tuesday March 13 - 12:30-2:00 pm – Copyright and Software

  • Tuesday April 10 - 12:30-2:00 pm – Trademarks

Wednesday, May 2, 2018 12:30 pm - 2:30 pm EDT (GMT -04:00)

UWaterloo Intellectual Property Workshop Series

IP Series Poster
Series Information:

  • Tuesday January 16 - 12:30-2:30 pm – IP 101 and Commercialization 

  • Tuesday February 13 - 12:30-2:00 pm – IP Case Study

  • Tuesday March 13 - 12:30-2:00 pm – Copyright and Software

  • Tuesday April 10 - 12:30-2:00 pm – Trademarks

Please join the Centre for Bioengineering and Biotechnology (CBB) and the Waterloo Institute for Nanotechnology (WIN) on Monday September 30, 2019 for a guest lecture by Dr. Ronald Li, Co-founder and CEO of Novoheart speaking on “Advances of Stem Cell Biotechnology for Development of Bio-artificial Human Heart” [Poster ]

Dr. Clay Radke
Dr. Clayton (Clay) J. Radke

Professor of Chemical and Biomolecular Engineering and Vision Science at the University California (Berkeley)

Title: Solute Partitioning and Diffusion in Hydrogels: Fundamentals of Drug and Comfort-Agent Delivery

Professor Sean Meehan: Cognitive-Motor Interactions and their Implications for Motor Learning-Based Interventions Post-Stroke

The efficacy of skilled practice in promoting beneficial brain reorganization to affect functional recovery has long been appreciated. However, current best practices to stroke rehabilitation are labour intensive and characterized by variable levels of functional recovery.

COVID-19 has brought disease and mortality at levels not seen from a respiratory virus for over 100 years. Immune responses to this virus, which can infect several different tissues, are poorly understood, including the role of antibodies in resolving the infection. In March 2020, we reoriented our lab to develop Enzyme-Linked ImmunoSorbent Assays (ELISA) for human antibody isotypes IgM, IgG and IgA produced in response to the SARS-CoV-2 spike protein. To date we have analyzed samples from 114 patients, including both PCR positive and PCR negative individuals.

Wednesday, October 28, 2020 12:10 pm - 1:00 pm EDT (GMT -04:00)

PROFS PRESENT ... Cognitive-Motor Interactions and Implications Post-Stroke

CBB Profs Present...Cognitive-motor interactions and their implications for motor learning-based interventions post-stroke with Sean Meehan

The efficacy of skilled practice in promoting beneficial brain reorganization to affect functional recovery has long been appreciated. However, current best practices to stroke rehabilitation are labour intensive and characterized by variable levels of functional recovery. In many cases, recovery of function in the stroke-affected limb is incomplete.